Clinical trial
Controlled Study to Evaluate the Efficacy and Safety of the Treatment With…
NCT00254514 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00254514 |
|---|---|
| Title | Controlled Study to Evaluate the Efficacy and Safety of the Treatment With Growth Hormone in Tibia Fractures |
| Official title | A Multi-centre, Randomised, Double-blind, Placebocontrolled, Parallel-group Trial Investigating the Efficacy and Safety of Norditropin® SimpleXx® in Tibia Fractures |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bone Fracture, Tibia Fractures |
| Intervention type | Drug |
| Interventions | somatropin |
| Enrollment | 407 |
| Start date | Aug 1, 2001 |
| Primary completion | Oct 1, 2003 |
| Completion | Oct 1, 2003 |
| First posted | Nov 16, 2005 |
| Last update posted | Jan 23, 2017 |
| Countries | Finland, France, Germany, Hungary, Israel, Norway, Poland, South Africa, Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: